Journal articles on the topic 'IL-5'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'IL-5.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Kotsimbos, ATC, and Q. Hamid. "IL-5 and IL-5 receptor in asthma." Memórias do Instituto Oswaldo Cruz 92, suppl 2 (December 1997): 75–91. http://dx.doi.org/10.1590/s0074-02761997000800012.
Full textTAKATSU, Kiyoshi. "Interleukin-5, IL-5." Journal of Japan Atherosclerosis Society 23, no. 10 (1996): 599–603. http://dx.doi.org/10.5551/jat1973.23.10_599.
Full textMalhi, Gin S. "DSM-5: Il buono, il cattivo, il brutto." Australian & New Zealand Journal of Psychiatry 47, no. 7 (June 28, 2013): 595–98. http://dx.doi.org/10.1177/0004867413496363.
Full textNAKANISHI, KENJI. "Interleukin cascade of IL-4,IL-5 and IL-2." Japanese Journal of Clinical Immunology 13, no. 5 (1990): 438–40. http://dx.doi.org/10.2177/jsci.13.438.
Full textStein, Miguel L., Joyce M. Villanueva, Bridget K. Buckmeier, Yoshiyuki Yamada, Alexandra H. Filipovich, Amal H. Assa'ad, and Marc E. Rothenberg. "Anti–IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels." Journal of Allergy and Clinical Immunology 121, no. 6 (June 2008): 1473–83. http://dx.doi.org/10.1016/j.jaci.2008.02.033.
Full textWarren, H. S., B. F. Kinnear, J. H. Phillips, and L. L. Lanier. "Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12." Journal of Immunology 154, no. 10 (May 15, 1995): 5144–52. http://dx.doi.org/10.4049/jimmunol.154.10.5144.
Full textEsnault, Stephane, Mats W. Johansson, and Sameer K. Mathur. "Eosinophils, beyond IL-5." Cells 10, no. 10 (October 1, 2021): 2615. http://dx.doi.org/10.3390/cells10102615.
Full textTakatsu, Kiyoshi, and Hiroshi Nakajima. "IL-5 and eosinophilia." Current Opinion in Immunology 20, no. 3 (June 2008): 288–94. http://dx.doi.org/10.1016/j.coi.2008.04.001.
Full textChung, K. F. "IL-5 in asthma." Thorax 57, no. 8 (August 1, 2002): 751. http://dx.doi.org/10.1136/thorax.57.8.751.
Full textMatthaei, Klaus I., Paul S. Foster, and Ian G. Young. "The role of interleukin-5 (IL-5 ) in vivo: studies with IL-5 deficient mice." Memórias do Instituto Oswaldo Cruz 92, suppl 2 (December 1997): 63–68. http://dx.doi.org/10.1590/s0074-02761997000800010.
Full textKOPF, MANFRED, GRAHAM LE GROS, ANTHONY J. COYLE, MARIE KOSCO-VTLBOIS, FRANK BROMBACHER, and Georges Kohler. "Immune Responses of IL-4, IL-5, IL-6 Deficient Mice." Immunological Reviews 148, no. 1 (December 1995): 45–69. http://dx.doi.org/10.1111/j.1600-065x.1995.tb00093.x.
Full textTakatsu, Kiyoshi. "Interleukin 5 (IL-5) and Its Receptor." Microbiology and Immunology 35, no. 8 (August 1991): 593–606. http://dx.doi.org/10.1111/j.1348-0421.1991.tb01591.x.
Full textSTEIN, M., A. MUNITZ, and M. ROTHENBERG. "Increased High Molecular Weight IL-5 Complex After Anti-IL-5 (Mepolizumab) Therapy." Journal of Allergy and Clinical Immunology 121, no. 2 (February 2008): S118. http://dx.doi.org/10.1016/j.jaci.2007.12.468.
Full textDickason, R. R., M. M. Huston, and D. P. Huston. "Delineation of IL-5 domains predicted to engage the IL-5 receptor complex." Journal of Immunology 156, no. 3 (February 1, 1996): 1030–37. http://dx.doi.org/10.4049/jimmunol.156.3.1030.
Full textOhbo, Kazuyuki, Hironobu Asoa, Kouro Taku, Nakamura Masataka, Yuji Klkuchi, Satoshl Takaki, and Katsulku Hirokawa. "Demonstration of a cross-talk between IL-2 and IL-5 in Phosphorylation of IL-2 and IL-5 receptor β chains." International Immunology 8, no. 6 (1996): 951–60. http://dx.doi.org/10.1093/intimm/8.6.951.
Full textYamaguchi, Y., T. Suda, H. Shiozaki, Y. Miura, Y. Hitoshi, A. Tominaga, K. Takatsu, and T. Kasahara. "Role of IL-5 in IL-2-induced eosinophilia. In vivo and in vitro expression of IL-5 mRNA by IL-2." Journal of Immunology 145, no. 3 (August 1, 1990): 873–77. http://dx.doi.org/10.4049/jimmunol.145.3.873.
Full textTAKATSU, SEISHI. "IL-5 and its receptor." Japanese Journal of Clinical Immunology 13, no. 5 (1990): 441–43. http://dx.doi.org/10.2177/jsci.13.441.
Full textNarendra, Dharani K., and Nicola A. Hanania. "Targeting IL-5 in COPD." International Journal of Chronic Obstructive Pulmonary Disease Volume 14 (May 2019): 1045–51. http://dx.doi.org/10.2147/copd.s155306.
Full textBAGLEY, C., A. LOPEZ, and M. VADAS. "New frontiers for IL-5." Journal of Allergy and Clinical Immunology 99, no. 6 (June 1997): 725–28. http://dx.doi.org/10.1016/s0091-6749(97)80002-4.
Full textLeung, Donald Y. M., Harold S. Nelson, Stanley J. Szefler, and William W. Busse. "Anti–IL-5 for hypereosinophilia." Journal of Allergy and Clinical Immunology 113, no. 1 (January 2004): 2. http://dx.doi.org/10.1016/j.jaci.2003.11.004.
Full textAmeri, Abdol A. "Weiterer IL-5-Antikörper verfügbar." MMW - Fortschritte der Medizin 159, no. 1 (January 2017): 67. http://dx.doi.org/10.1007/s15006-017-9167-7.
Full textGregory, Bernard, Antje Kirchem, Simon Phipps, Phillipe Gevaert, Carol Pridgeon, Sara M. Rankin, and Douglas S. Robinson. "Differential Regulation of Human Eosinophil IL-3, IL-5, and GM-CSF Receptor α-Chain Expression by Cytokines: IL-3, IL-5, and GM-CSF Down-Regulate IL-5 Receptor α Expression with Loss of IL-5 Responsiveness, but Up-Regulate IL-3 Receptor α Expression." Journal of Immunology 170, no. 11 (June 1, 2003): 5359–66. http://dx.doi.org/10.4049/jimmunol.170.11.5359.
Full textWebb, Dianne C., Andrew N. J. McKenzie, Aulikki M. L. Koskinen, Ming Yang, Joërg Mattes, and Paul S. Foster. "Integrated Signals Between IL-13, IL-4, and IL-5 Regulate Airways Hyperreactivity." Journal of Immunology 165, no. 1 (July 1, 2000): 108–13. http://dx.doi.org/10.4049/jimmunol.165.1.108.
Full textFort, Madeline M., Jeanne Cheung, David Yen, Joana Li, Sandra M. Zurawski, Sylvia Lo, Satish Menon, et al. "IL-25 Induces IL-4, IL-5, and IL-13 and Th2-Associated Pathologies In Vivo." Immunity 15, no. 6 (December 2001): 985–95. http://dx.doi.org/10.1016/s1074-7613(01)00243-6.
Full textTominaga, A., T. Takahashi, Y. Kikuchi, S. Mita, S. Naomi, N. Harada, N. Yamaguchi, and K. Takatsu. "Role of carbohydrate moiety of IL-5. Effect of tunicamycin on the glycosylation of IL-5 and the biologic activity of deglycosylated IL-5." Journal of Immunology 144, no. 4 (February 15, 1990): 1345–52. http://dx.doi.org/10.4049/jimmunol.144.4.1345.
Full textZhu, W., N. Liu, Y. Zhao, H. Jia, B. Cui, and G. Ning. "Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with Graves’ disease." Journal of Endocrinological Investigation 33, no. 10 (March 22, 2010): 751–55. http://dx.doi.org/10.1007/bf03346682.
Full textH, Ha, Spicer T, He Xy, Chen J, Boyd R, Tran G, Hodgkinson Sj, and Hall BM. "IL-4 AND IL-5 THERAPY INHIBITS HEYMANN NEPHRITIS (HN)." Nephrology 7, no. 1 (February 2002): A113. http://dx.doi.org/10.1046/j.1440-1797.2002.00007-1-113.x.
Full textHashiguchi, Masaaki, Yuji Kashiwakura, Yumiko Kanno, Hidefumi Kojima, and Tetsuji Kobata. "IL-21 and IL-5 coordinately induce surface IgA+ cells." Immunology Letters 224 (August 2020): 21–27. http://dx.doi.org/10.1016/j.imlet.2020.05.004.
Full textSolinger, Alan M. "IL-1-5 Blocking IL-1β in type 2 diabetes." Cytokine 52, no. 1-2 (October 2010): 10. http://dx.doi.org/10.1016/j.cyto.2010.07.043.
Full textBourdenet, V., G. Devouassoux, B. Antoine, C. Bernier, O. Carpentier, C. Chenivesse, A. Du Thanh, et al. "Eczéma paradoxal sous biothérapie ciblant l’axe IL-5/IL-5R." Annales de Dermatologie et de Vénéréologie - FMC 2, no. 8 (November 2022): A64. http://dx.doi.org/10.1016/j.fander.2022.09.062.
Full textDrick, Nora, Katrin Milger, Benjamin Seeliger, Jan Fuge, Stephanie Korn, Roland Buhl, Maren Schuhmann, et al. "Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma." Journal of Asthma and Allergy Volume 13 (November 2020): 605–14. http://dx.doi.org/10.2147/jaa.s270298.
Full textReiman, Rachael M., Robert W. Thompson, Carl G. Feng, Danielle Hari, Rachel Knight, Allen W. Cheever, Helene F. Rosenberg, and Thomas A. Wynn. "Interleukin-5 (IL-5) Augments the Progression of Liver Fibrosis by Regulating IL-13 Activity." Infection and Immunity 74, no. 3 (March 2006): 1471–79. http://dx.doi.org/10.1128/iai.74.3.1471-1479.2006.
Full textHall, B., K. Plain, M. Nomura, N. Verma, G. Tran, R. Boyd, C. Robinson, and S. Hodgkinson. "ALLOGRAFT TOLERANCE MEDIATING CD4+T CELLS DEPEND UPON INTERLEUKIN-5 (IL-5), NOT IL-4." Transplantation 86, Supplement (July 2008): 136. http://dx.doi.org/10.1097/01.tp.0000332495.28926.ce.
Full textNamkung, J. H., J. E. Lee, E. Kim, H. J. Cho, S. Kim, E. S. Shin, E. Y. Cho, and J. M. Yang. "IL-5 and IL-5 receptor alpha polymorphisms are associated with atopic dermatitis in Koreans." Allergy 62, no. 8 (August 2007): 934–42. http://dx.doi.org/10.1111/j.1398-9995.2007.01445.x.
Full textTAKATSU, Kiyoshi. "Structure and Function of IL-5 Receptor." YAKUGAKU ZASSHI 115, no. 8 (1995): 570–83. http://dx.doi.org/10.1248/yakushi1947.115.8_570.
Full textHatzistilianou, M., C. Aggouridaki, B. Tsotsou, A. Thymi, G. Koulouses, and A. Stogias. "Serum TNF-α, IL-1β, IL-4 and IL-5 levels in bronchial asthma." Immunology Letters 56 (May 1997): 155. http://dx.doi.org/10.1016/s0165-2478(97)85619-2.
Full textHatzistilianou, M. "Serum TNF-α, IL-1β, IL-4 and IL-5 levels in bronchial asthma." Immunology Letters 56, no. 1-3 (May 1997): 155. http://dx.doi.org/10.1016/s0165-2478(97)87457-3.
Full textBrown, Pamela M., Philip Tagari, Kevin R. Rowan, Violeta L. Yu, Gary P. O'Neill, C. Russell Middaugh, Gautam Sanyal, Anthony W. Ford-Hutchinson, and Donald W. Nicholson. "Epitope-labeled Soluble Human Interleukin-5 (IL-5) Receptors." Journal of Biological Chemistry 270, no. 49 (December 8, 1995): 29236–43. http://dx.doi.org/10.1074/jbc.270.49.29236.
Full textMORI, A., O. KAMINUMA, T. MIKAMI, S. INOUE, Y. OKUMURA, K. AKIYAMA, and H. OKUDAIRA. "Transcriptional control of the IL-5 gene by human helper T cells: IL-5 synthesis is regulated independently from IL-2 or IL-4 synthesis." Journal of Allergy and Clinical Immunology 103, no. 5 (May 1999): S429—S436. http://dx.doi.org/10.1016/s0091-6749(99)70158-2.
Full textRandall, T. D., F. E. Lund, J. W. Brewer, C. Aldridge, R. Wall, and R. B. Corley. "Interleukin-5 (IL-5) and IL-6 define two molecularly distinct pathways of B-cell differentiation." Molecular and Cellular Biology 13, no. 7 (July 1993): 3929–36. http://dx.doi.org/10.1128/mcb.13.7.3929-3936.1993.
Full textRandall, T. D., F. E. Lund, J. W. Brewer, C. Aldridge, R. Wall, and R. B. Corley. "Interleukin-5 (IL-5) and IL-6 define two molecularly distinct pathways of B-cell differentiation." Molecular and Cellular Biology 13, no. 7 (July 1993): 3929–36. http://dx.doi.org/10.1128/mcb.13.7.3929.
Full textJohnson, Teresa R., and Barney S. Graham. "Secreted Respiratory Syncytial Virus G Glycoprotein Induces Interleukin-5 (IL-5), IL-13, and Eosinophilia by an IL-4-Independent Mechanism." Journal of Virology 73, no. 10 (October 1, 1999): 8485–95. http://dx.doi.org/10.1128/jvi.73.10.8485-8495.1999.
Full textUings, Iain, and Murray McKinnon. "Development of IL-5 Receptor Antagonists." Current Pharmaceutical Design 8, no. 20 (September 1, 2002): 1837–44. http://dx.doi.org/10.2174/1381612023393800.
Full textKhan, S. "Anti-IL-5 therapy and DRESS." Canadian Medical Association Journal 182, no. 9 (June 14, 2010): 941. http://dx.doi.org/10.1503/cmaj.110-2054.
Full textLakatta, Edward G. "IL-5 The heart of survival." Journal of Molecular and Cellular Cardiology 34, no. 10 (October 2002): A6. http://dx.doi.org/10.1016/s0022-2828(02)90255-5.
Full textEinecke, Dirk. "Anti-IgE oder Anti-IL 5?" MMW - Fortschritte der Medizin 159, no. 15 (September 2017): 70. http://dx.doi.org/10.1007/s15006-017-0015-6.
Full textSUTTON, S., A. ASSAAD, and M. ROTHENBERG. "Anti-IL-5 and hypereosinophilic syndromes." Clinical Immunology 115, no. 1 (April 2005): 51–60. http://dx.doi.org/10.1016/j.clim.2005.02.006.
Full textOtt, Christina. "IL-5-Rezeptor-Antikörper ergänzt Therapieoptionen." MMW - Fortschritte der Medizin 160, no. 4 (March 2018): 58. http://dx.doi.org/10.1007/s15006-018-0251-4.
Full textZahn, Stefan, Paul Godillot, Akihiko Yoshimura, and Irwin Chaiken. "IL-5-INDUCED JAB–JAK2 INTERACTION." Cytokine 12, no. 9 (September 2000): 1299–306. http://dx.doi.org/10.1006/cyto.2000.0718.
Full textRussell, Richard, and Christopher E. Brightling. "Anti-IL-5 for Severe Asthma." Chest 150, no. 4 (October 2016): 766–68. http://dx.doi.org/10.1016/j.chest.2016.06.013.
Full text